Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Thrombosis Research|June 12, 2012
Side effects of anti-angiogenic drugsFrancesca Elice, Francesco RodeghieroExpert Opinion on Investigational Drugs|November 1, 2005
Immunomodulatory drugs in multiple myelomaMaurizio Zangari, Francesca Elice, Guido TricotSeminars in Thrombosis and Hemostasis|May 26, 2007
Hemostatic dysfunction in paraproteinemias and amyloidosisMaurizio Zangari, Francesca Elice, Louis Fink, et al.Expert Review of Anticancer Therapy|March 7, 2007
Thrombosis in multiple myelomaMaurizio Zangari, Francesca Elice, Louis Fink, et al.Best Practice & Research. Clinical Haematology|March 17, 2009
Thrombosis associated with angiogenesis inhibitorsFrancesca Elice, Francesco Rodeghiero, Anna Falanga, et al.British Journal of Haematology|August 3, 2006
Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolismFrancesca Elice, Louis Fink, Guido Tricot, et al.American Journal of Hematology|September 27, 2008
Hemostatic complications of angiogenesis inhibitors in cancer patientsFrancesca Elice, Jack Jacoub, Frederick R Rickles, et al.Haematologica|September 21, 2004
Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myelomaMonica Galli, Francesca Elice, Claudia Crippa, et al.Haematologica|November 5, 2002
Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myelomaElisabetta Novella, Ilaria Giaretta, Francesca Elice, et al.American Journal of Hematology|May 9, 2006
Prolonged overall survival with second on-demand autologous transplant in multiple myelomaFrancesca Elice, Roberto Raimondi, Alberto Tosetto, et al.Pageof 3